Source: www.biotechnologyhealthcare.com Austin, Texas ? Introgen Therapies announced initiation of a Phase II clinical trial of INGN 241 in patients with metastatic melanoma.
Expert Perspectives Into Empowering Patients With OTC Relief
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Expert Insights on Rapid Weight Loss, Semaglutide, and Aesthetic Procedures
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York
Derm In The News: September 17-23